LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | NVP-TAE684 | 0.04 | uM | LJP6 | 2 | K18 | 72 | hr | 868 | 3206 | 3486 | 0.9196 | 0.8929 |
MDA-MB-231 | NVP-TAE684 | 0.04 | uM | LJP6 | 3 | K18 | 72 | hr | 868 | 3190 | 3486 | 0.9150 | 0.8868 |
MDA-MB-231 | Palbociclib | 0.04 | uM | LJP6 | 1 | E18 | 72 | hr | 868 | 2687 | 3486 | 0.7707 | 0.6947 |
MDA-MB-231 | Palbociclib | 0.04 | uM | LJP6 | 2 | E18 | 72 | hr | 868 | 2760 | 3486 | 0.7917 | 0.7226 |
MDA-MB-231 | Palbociclib | 0.04 | uM | LJP6 | 3 | E18 | 72 | hr | 868 | 2674 | 3486 | 0.7670 | 0.6897 |
MDA-MB-231 | PD0325901 | 0.04 | uM | LJP5 | 1 | C06 | 72 | hr | 868 | 2068 | 3486 | 0.5932 | 0.4583 |
MDA-MB-231 | PD0325901 | 0.04 | uM | LJP5 | 2 | C06 | 72 | hr | 868 | 2184 | 3486 | 0.6264 | 0.5026 |
MDA-MB-231 | PD0325901 | 0.04 | uM | LJP5 | 3 | C06 | 72 | hr | 868 | 2118 | 3486 | 0.6075 | 0.4774 |
MDA-MB-231 | PD0325901 | 0.04 | uM | LJP6 | 1 | E06 | 72 | hr | 868 | 1922 | 3486 | 0.5513 | 0.4025 |
MDA-MB-231 | PD0325901 | 0.04 | uM | LJP6 | 2 | E06 | 72 | hr | 868 | 2293 | 3486 | 0.6577 | 0.5442 |
MDA-MB-231 | PD0325901 | 0.04 | uM | LJP6 | 3 | E06 | 72 | hr | 868 | 2397 | 3486 | 0.6875 | 0.5839 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 1 | I12 | 72 | hr | 868 | 3982 | 3486 | 1.1422 | 1.1893 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 2 | I12 | 72 | hr | 868 | 4166 | 3486 | 1.1949 | 1.2596 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 3 | I12 | 72 | hr | 868 | 4106 | 3486 | 1.1777 | 1.2366 |
MDA-MB-231 | PD184352 | 0.04 | uM | LJP5 | 1 | L12 | 72 | hr | 868 | 3408 | 3486 | 0.9775 | 0.9701 |
MDA-MB-231 | PD184352 | 0.04 | uM | LJP5 | 2 | L12 | 72 | hr | 868 | 3714 | 3486 | 1.0653 | 1.0869 |
MDA-MB-231 | PD184352 | 0.04 | uM | LJP5 | 3 | L12 | 72 | hr | 868 | 3639 | 3486 | 1.0438 | 1.0583 |
MDA-MB-231 | Pelitinib | 0.04 | uM | LJP5 | 1 | I18 | 72 | hr | 868 | 3879 | 3486 | 1.1126 | 1.1499 |
MDA-MB-231 | Pelitinib | 0.04 | uM | LJP5 | 2 | I18 | 72 | hr | 868 | 3816 | 3486 | 1.0945 | 1.1259 |
MDA-MB-231 | Pelitinib | 0.04 | uM | LJP5 | 3 | I18 | 72 | hr | 868 | 3528 | 3486 | 1.0119 | 1.0159 |
MDA-MB-231 | PF431396 | 0.04 | uM | LJP5 | 1 | E12 | 72 | hr | 868 | 3308 | 3486 | 0.9488 | 0.9319 |
MDA-MB-231 | PF431396 | 0.04 | uM | LJP5 | 2 | E12 | 72 | hr | 868 | 3323 | 3486 | 0.9531 | 0.9376 |
MDA-MB-231 | PF431396 | 0.04 | uM | LJP5 | 3 | E12 | 72 | hr | 868 | 3357 | 3486 | 0.9629 | 0.9506 |
MDA-MB-231 | PF477736 | 0.04 | uM | LJP5 | 1 | J24 | 72 | hr | 868 | 2726 | 3486 | 0.7819 | 0.7096 |
MDA-MB-231 | PF477736 | 0.04 | uM | LJP5 | 2 | J24 | 72 | hr | 868 | 3418 | 3486 | 0.9804 | 0.9739 |